While gut-derived signals such as GLP-1 have become a primary therapeutic target for obesity and diabetes treatment, diverse myokines and adipokines also mediate crosstalk between the muscles, adipose tissue, and other organs, including the brain, to modulate systemic energy metabolism and insulin sensitivity15,16. This evidence concerns the gene INS and diabetes mellitus.